Ovid Therapeutics · 2 days ago
Clinical Operations (AD, Director, Sr Director)
New York, NY
Full-time
Hybrid
Director/Executive
$200K/yr - $270K/yr
10+ years expOvid Therapeutics Inc. is a New York-based biopharmaceutical company focused on developing small molecule medicines for brain conditions. The role involves overseeing and managing all aspects of clinical operations for high-priority programs, ensuring effective execution of clinical studies through collaboration with internal teams and external partners.
BiopharmaBiotechnologyHealth Care
Responsibilities
Manage interactions with and between clinical monitors, biostatistics, medical writing, safety and other key stakeholders and effectively interact with scientists and managers within and outside Clinical Research Organization (CRO), vendors, and partners. Have strong outsourcing experience
Provide program-level sponsor’s operational oversight of our strategic partners and other vendors to ensure the effective execution of the clinical studies on time, with high quality and within agreed budget
Develop and lead the program-level operational strategy and planning on assigned programs in close collaboration with our strategic partners and other vendors
May also be responsible for contributing to a clinical development plan within a program moving into a new or subdivision of a current indication
Organize and lead study specific meetings
Develop scientifically robust, operationally feasible and clear protocol concepts and protocols, robust, data monitoring plans, and other study documents
Develop operational strategy along with CRO/vendors aligned with the program strategy and incorporating local and country-level input
Lead and oversee the strategic planning, implementation and execution of clinical trials across key programs in accordance with project timelines, budget, and quality standards
Develop and manage comprehensive program project plans, including but not limited to, study protocols, clinical trial budgets, timelines, enrollment and risk mitigation strategies
Collaborate cross functionally with internal teams, including Clinical Development, Regulatory Affairs, Biostatistics, Translational Medicine and Program Leadership to ensure alignment on clinical trial objectives and milestones
Provide operational expertise and strategic input into the development of Clinical Development Plans (CDP), supporting the overall clinical strategy for the program
Serve as the point of contact for CROs and vendors, overseeing their performance and ensuring adherence to contractual agreements, timelines and quality standards
Ensure compliance with regulatory requirements, ICH-GCP requirements, and company SOPs throughout all stages of clinical trial conduct
Oversee the collection, analysis and interpretation of clinical trial data, working closely with Clinical Development, Biostatistics and Data Management teams to ensure data accuracy and integrity
Contribute to the preparation and review of clinical study documents including the Investigator Brochure, Investigational New Drug Applications (IND), study protocols, clinical study reports, applicable sections of New Drug Applications (NDA) and or Marketing Authorization Application (MAA), updates to the IND, NDA and other safety reports
Qualification
Required
10+ years of clinical research / project management experience preferably with both a sponsor company and CRO managing outsourced clinical trials within quality, timeline, and budget expectations
Detailed understanding and experience in all aspects of clinical protocol development, implementation, regulatory submissions, and overall drug development
Ability to establish operational plans and support the CRO/vendor in the execution of the plans
Understanding of clinical development within two or more phases of trials (Phase I, II, III, IV) and a working understanding of cross functional drug development
Preferred
Prior investigator site and/or monitoring experience is advantageous
Deep knowledge of clinical trial methodology, regulatory and compliance requirements governing clinical trials and experience in the development of study designs is desirable
Adaptability, flexibility, independence, and resourcefulness to roll-up-sleeves and multi-task so to thrive in a small company, fast-paced environment
Marked proficiency in clinical and/or medical writing
Broad experience in early-stage and late-stage development programs
Demonstrated experience working with FDA, MHRA and ICH GCP guidelines to ensure the appropriate conduct of clinical studies in the United States
Extensive knowledge of regulatory guidelines and experience with worldwide regulatory agencies in therapeutic product development; global experience highly preferred
Outstanding presentation, written and oral skills are required. A clear communicator who can influence effectively both internally and externally
Bring a history of great collaboration and teamwork with the ability to motivate and influence others; have a reputation for successful partnering with internal and external stakeholders
Have the ability and the drive to succeed in a small biotech organization. Interest to grow in the function to advance new technologies in new therapies. Must be self-motivated, proactive, work well under pressure and deadlines, and thrive in a small 'all hands-on deck' environment
Solution-oriented thinker who possesses a 'can do' attitude with a strong sense of urgency
Create a balance of analytical and methodical problem solving with creative and flexible solutions
Company
Ovid Therapeutics
Ovid Therapeutic's purpose is to solve intractable medical problems.
11-50 employees
H1B Sponsorship
Ovid Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
Funding
Current Stage
Public CompanyTotal Funding
$272.12MKey Investors
ImmedicaFidelity
2025-10-03Post Ipo Equity· $81M
2025-06-25Post Ipo Debt· $7M
2019-10-04Post Ipo Equity
Leadership Team
Meg Alexander
President & COO
Petra Kaufmann
Chief Medical Officer
Recent News
2025-12-18
MarketScreener
2025-12-18
Company data provided by crunchbase